ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681266; 2) Community: the network communities that were significantly associated with the response to NSC 681266; 3) Molecule: the relationships between components within communities and NSC 681266; 4) MDR: the compounds that were significantly associated with the NSC 681266.

NSC Compound Enrichment Correlation
NSC 735037 Camptothecin Derivative 0.00404192617431249 0.20299223
NSC 749152 Null 0.00404192617431249 0.49781002
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.00404192617431249 0.17587014
NSC 93354 Null 0.00404192617431249 0.3152097
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.00411343439683528 0.36275803
NSC 145168 1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- 0.00414350254426684 0.33914393
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.00414350254426684 0.18263803
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.00414350254426684 0.22363389
NSC 600684 Null 0.00414350254426684 0.12265725
NSC 627669 Null 0.00414350254426684 0.32725882
Total:85  Current:11    [First] [Prev] [Next] [Last]